Skip to main content
FinSpry Logo
FinSpry
JNJ logo
JNJ
(NYSE)
Johnson & Johnson
$243.04-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Johnson & Johnson (JNJ) Stock Price & Financial Analysis

Johnson & Johnson Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$241.87 - $247.21
52-Week High$251.71
52-Week Low$141.50
Open$245.11
Volume6.58M
Average Volume (3M)6.58M
Market Cap590.44B
Shares Outstanding2.43B
P/E Ratio (TTM)22.13
Forward P/E11.66
Price to Sales (P/S)6.30
Price to Book (P/B)7.27
EV/EBITDA15.13
Revenue (TTM)94.19B
Net Income (TTM)26.80B
Free Cash Flow (TTM)19.31B
EPS (TTM)$10.99
Profit Margin28.46%
Operating Margin27.17%
Return on Equity (ROE)32.87%
Debt to Equity0.59
50-Day MA$238.40
200-Day MA$197.97
52-Week Change59.30%
Annual Dividend$5.20
Dividend Yield2.13%
Payout Ratio47.32%
Last Dividend Ex-DateFeb 24, 2026

Frequently Asked Questions About Johnson & Johnson

What is the current stock price for JNJ?

As of the latest trading session, JNJ stock trades at $243.04. The 52-week range is $141.50–$251.71, with a day range of $241.87–$247.21.

What is the P/E ratio for JNJ?

Johnson & Johnson's trailing P/E ratio is 22.1, meaning investors pay $22.1 for every $1 of annual earnings. The forward P/E is 11.7, reflecting analyst expectations for future earnings. Johnson & Johnson operates in the Healthcare sector.

Does JNJ pay dividends?

Yes, Johnson & Johnson pays a 2.13% annual dividend yield ($5.20 per share). The payout ratio is 47.3%. The last ex-dividend date was 2026-02-24.

What do analysts recommend for JNJ?

Based on 16 analysts, the consensus for JNJ is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of JNJ?

Johnson & Johnson's market capitalization is $590.44B, classifying it as a mega-cap company. Johnson & Johnson operates in the Healthcare sector within the Drug Manufacturers - General industry.